The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses

Despite new treatment modalities, including targeted therapies and checkpoint inhibitors, cytotoxic chemotherapy remains central in the care of patients with lung tumors. Use of the pulmonary route to deliver chemotherapy has been proved to be feasible and safe in phase I, Ib/IIa and II trials for l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosière, Rémi, Berghmans, Thierry, De Vuyst, Paul, Amighi, Karim, Wauthoz, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468657/
https://www.ncbi.nlm.nih.gov/pubmed/30866545
http://dx.doi.org/10.3390/cancers11030329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468657/
https://www.ncbi.nlm.nih.gov/pubmed/30866545
http://dx.doi.org/10.3390/cancers11030329

Ejemplares similares